Patent · US Active

Substituted oxopyridine derivatives

US11180471B2 · kind B2 · utility

0Cited by

3References

67Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Eloisa JIMENEZ NUNEZ · Wuppertal, DE
Jens Ackerstaff · Mülheim an der Ruhr, DE
Susanne ROEHRIG · Hilden, DE
Alexander Hillisch · Solingen, DE
Katharina MEIER · Mettmann, DE
Stefan Heitmeier · Wülfrath, DE
Adrian Tersteegen · Wuppertal, DE
Jan STAMPFUSS · Goldkronach, DE
Pascal ELLERBROCK · Düsseldorf, DE
Daniel Meibom · Leverkusen, DE
Dieter Lang · Velbert, DE

Key dates

Filing date	Aug 8, 2019
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Aug 8, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.